Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

AMPLIA THERAPEUTICS LIMITED

Date of this announcement

Wednesday January 19, 2022

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

New class - code

Option Expiring 31-DEC-2023 EX $0.28

377,166

18/01/2022

to be confirmed

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

AMPLIA THERAPEUTICS LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

16165160841

1.3

ASX issuer code

ATX

  1. The announcement is New announcement
  2. Date of this announcement

19/1/2022

Notification of Issue, Conversion or Payment up of Unquoted

2 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

For personal use only

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code ("new class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B

only

ASX +security code

+Security description

New class - code to be confirmed

Option Expiring 31-DEC-2023 EX $0.28

+Security type

ISIN code

Options

use

Date the +securities the subject of this notification were issued

18/1/2022

Will all the +securities issued in this class rank equally in all respects from their issue date?

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

personal

No

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under

listing rule 6.1?

No

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being

issued.

https://www.ampliatx.com/site/PDF/4e23cb8c-5cbb-45f5-83d3-fecd2aeb9d06/NoticeofAnnualGeneralMeetingProxyForm

Options Details

+Security currency

Exercise price

Expiry date

AUD - Australian Dollar

AUD 0.28000000

31/12/2023

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of

For

company option

Other

Description

ATX Ordinary Fully Paid Shares

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://www.ampliatx.com/site/PDF/4e23cb8c-5cbb-45f5-83d3-fecd2aeb9d06/NoticeofAnnualGeneralMeetingProxyForm

Notification of Issue, Conversion or Payment up of Unquoted

4 / 7

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Any other information the entity wishes to provide about the +securities the subject of this notification

Options issued pursuant to Employee Share Option Plan. The Employee Share Option Plan was approved by shareholders at the Company's Annual General Meeting held on 30 August 2019.

Issue details

onlyusepersonalFor

Number of +securities

377,166

Notification of Issue, Conversion or Payment up of Unquoted

5 / 7

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Amplia Therapeutics Ltd. published this content on 18 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 January 2022 22:11:09 UTC.